Chinese Firm Makes Gilead Drug in Virus Fight, Raising IP Fears

(Bloomberg) -- A Chinese drugmaker said it has started mass-producing an experimental treatment from Gilead Sciences Inc. that has shown potential to fight the novel coronavirus, adding to concerns...
BQ Install

Bloomberg Quint

Add BloombergQuint App to Home screen.